On March 10, 2024, Kevin E. Lofton notified the Board of Directors of Gilead Sciences, Inc. (the ?Company?), of his decision to retire from the Board, effective as of the conclusion of his term at the Company?s next annual meeting of stockholders to be held on May 8, 2024. Mr. Lofton?s decision to retire was not a result of any disagreement with the Board or management of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
65.42 USD | +0.23% | -2.01% | -19.24% |
Apr. 26 | TD Cowen Adjusts Price Target on Gilead Sciences to $85 From $90 | MT |
Apr. 26 | Jefferies Adjusts Gilead Sciences' Price Target to $80 From $95 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.24% | 81.58B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Gilead Sciences, Inc. Announces Retirement of Kevin E. Lofton from the Board, Effective May 8, 2024